Trial intelligence / Profile preview

TUDCA versus UDCA for liver cirrhosis

ChiCTR-TRC-12001939Phase 4Completed

Sponsor
Department of Gastroenterology, Wuhan Union Hospital
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tauroursodeoxycholic acid in Cirrhosis (2 arms), sponsored by Department of Gastroenterology, Wuhan Union Hospital. Primary endpoints: alanine aminotransferase, aspartate aminotransferase and 2 more. Started Jun 2009; status: completed.

02

Drugs

tauroursodeoxycholic acid
03

Conditions

Cirrhosis

Beyond the preview

Go deeper on ChiCTR-TRC-12001939.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12001939.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call